Hunt for improved monoclonals against coronavirus gathers pace.

Autor: Garber, Ken
Zdroj: Nature Biotechnology; 2021, Vol. 39 Issue 1, p9-12, 4p
Abstrakt: Following mixed results in the clinic against COVID-19, antibody engineers are further optimizing SARS-CoV-2 antibodies with the aim of improving outcomes. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index